HemaSphere (Apr 2022)

B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY

  • P Rodriguez-Otero,
  • B Dholaria,
  • E Askari,
  • D Reece,
  • N van de Donk,
  • A Chari,
  • H Goldschmidt,
  • A Krishnan,
  • T Martin,
  • M Mateos,
  • D Morillo,
  • C Rodriguez,
  • L Rosinol,
  • J San-Miguel,
  • A Balari,
  • R Wäsch,
  • K Weisel,
  • R Verona,
  • S Lin,
  • T Prior,
  • M Wade,
  • B Weiss,
  • J Goldberg,
  • A Oriol,
  • P Hari

DOI
https://doi.org/10.1097/01.HS9.0000829556.56345.01
Journal volume & issue
Vol. 6
pp. 7 – 8

Abstract

Read online

No abstracts available.